3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: October 20, 2015
Period of Report: October 15, 2015
Accession Number: 0001546927-15-000261

View Document ↗ View on SEC.gov ↗